Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with achondroplasia.

Autor: Savarirayan R; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia. ravi.savarirayan@mcri.edu.au., Hoover-Fong J; Greenberg Center for Skeletal Dysplasias, McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University, Baltimore, MD, USA., Ozono K; Centre for Promoting Treatment of Intractable Diseases, ISEIKAI International General Hospital, Osaka, Japan., Backeljauw P; Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Cormier-Daire V; Université Paris Cité, institut Imagine, Hôpital Necker Enfants maladies, Paris, France., DeAndrade K; The Little Legs Big Heart Foundation, West Palm Beach, FL, USA., Ireland P; Queensland Health, Brisbane, Queensland, Australia., Irving M; Guy's and St Thomas' NHS Foundation Trust, London, UK., Llerena Junior J; Centro de Genética Médica, FIOCRUZ, Rio de Janeiro, Brazil., Maghnie M; Paediatric Clinic, Endocrinology, University of Genova, Genova, Italy., Menzel M; Atlantic health system, Morristown, NJ, USA.; Columbia University, New York, NY, USA., Merchant N; UT Southwestern Medical Center, Children's Health, Dallas, TX, USA., Mohnike K; Children's Hospital, Magdeburg, Germany., Iruretagoyena SN; Fundación ALPE Acondroplasia, Gijón, Spain., Okada K; University of Tokyo, Tokyo, Japan., Fredwall SO; Sunnaas Rehabilitation Hospital, Nesodden, Norway.

Publikováno v: Nature reviews. Endocrinology [Nat Rev Endocrinol] 2025 Jan 06. Date of Electronic Publication: 2025 Jan 06.